Postdoctoral Researcher in Advanced Viral Vector Technology & Bioprocess Development KU Leuven in Belgium

KU Leuven’s LMVGT and ADVANTAGE labs are recruiting a Postdoctoral Researcher in Advanced Viral Vector Technology & Bioprocess Development for a fully funded 3-year project starting in Q3 2026.

This opportunity is centered on gene therapy, viral vector technology, viral vector engineering, bioprocess development, lentiviral and retroviral vector production, virus-like particles (VLPs), and CRISPR gene editing. The project aims to develop scalable manufacturing platforms that support rare disease modelling and next-generation gene therapy research.

The position is based in Leuven, Belgium, within the Leuven Viral Vector Core (LVVC), which offers state-of-the-art viral vector production facilities and a highly collaborative, international, multidisciplinary research environment.

Ideal candidates should have strong expertise in viral vector engineering and manufacturing, upstream and downstream bioprocess development, and advanced CRISPR technologies. The post is explicitly advertised as a postdoctoral opening and is described as fully funded.

Interested applicants should follow the application link referenced in the post and apply through the linked portal. The post does not mention a deadline.